Valmark Advisers’s GE HealthCare GEHC Stock Holding History

Valmark Advisers’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,360	Closed	-$222K	–	605
2024 Q3	$222K	Buy	+2,360	New	+$198K	﹤0.01%	562

Other funds holding GEHC

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Valmark Advisers's GEHC Position: Q4 2024 in Review

Valmark Advisers sold out of GE HealthCare (GEHC) in Q4 2024, closing a stake of 2,360 shares — an estimated $222K sold.

Valmark Advisers first reported a position in GEHC in Q3 2024 and held it in 1 quarter. The position peaked at $222K in Q3 2024. 1,329 funds tracked by Wall St. Rank hold GEHC as of Q4 2024.

Valmark Advisers reported no remaining GE HealthCare position as of Q4 2024 after selling out during the quarter.
Valmark Advisers sold 2,360 GE HealthCare shares in Q4 2024, an estimated $222K.
Valmark Advisers first reported a position in GE HealthCare in Q3 2024 and held it in 1 quarter.
Valmark Advisers's GE HealthCare position peaked at $222K in Q3 2024.
1,329 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2024.

Based on Valmark Advisers's 13F filing for Q4 2024, filed 30 Jan 2025.